Member Info for goldust88

From Proactive...

Morgan Sindall Group PLC - Morgan Sindall rises as order book remains unchanged despite coronavirus disruption
Morgan Sindall Group PLC (LON:MGNS) shares were on the up on Thursday as the group said its order book had remained unchanged from the year-end position despite disruption caused by the coronavirus pandemic.

In a trading update, the construction group said its secured workload as of 31 March was £7.6bn and that its balance sheet was in “good shape” with net cash of £174mln as of 5 May.

The company also said around 80% of its construction sites were currently operational as well as 75% of infrastructure projects and 70% of fit out projects.

“With this high-quality workload and with the balance sheet in good shape, the group is well-positioned to successfully navigate through these current uncertain times and emerge primed for future success in the medium and longer term”, the company said.

However, Morgan Sindall continued to suspend its forward guidance due to the pandemic uncertainty.

“Our decentralised structure has allowed us to adapt quickly to these evolving circumstances and to rapidly adopt new ways of working, which will stand us in good stead for the future”, said chief executive John Morgan.

“Our strategy remains unchanged, focused on building long-term workstreams in markets that remain attractive. Supported by a strong balance sheet, the actions taken put the Group on the best footing to ensure its continued success", he added.

In a note, analysts at Peel Hunt retained their ‘add’ rating and 1,500p price target on the firm, saying the update provided “encouragement” regarding site reopenings and productivity.

“In addition, net cash of £174mln implies a likely positive average daily net cash position for [the 2020 financial year]”, the broker said, although they added that investors “are likely to look for further evidence of recovery” before rerating the share price.

Excellent results out this morning and actually doing more work than I expected in Lockdown. Will soon be back to normal trading. Also I expect that profits could well be up this year as what happens when less work is generally available for workmen and suppliers is that their prices drop to contractors like MGNS thus improving profits or in MGNS case making up for any shortfall in tutnover. Alsos they have a huge future order book and with lockdown easing this weekend all should be back to normal soon. Not a lot of shares in free float so I would get in quick if your keen as could soon get bavk to normal share price of about 1800

Just seen the news -should be very good for WSG

UP 20% already on level 2-this is going to rocket

Synairgen plc Extension of clinical study in COVID-19 patients
30/04/2020 12:09pm
UK Regulatory (RNS & others)

Synairgen (LSE:SNG)
Intraday Stock Chart

Thursday 30 April 2020

Click Here for more Synairgen Charts.
TIDMSNG

RNS Number : 5139L

Synairgen plc

30 April 2020

Press release

Synairgen plc

('Synairgen' or the 'Company')

Approval received to extend SG016 clinical study of SNG001 in COVID-19 to initiate patients in the home environment

Southampton, UK - 30 April 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it has received approvals to extend the SG016 trial to patients with SARS-CoV-2 in the home environment. The objective is to initiate dosing with SNG001 (or placebo) earlier in the infection cycle, and before severe lower respiratory tract symptoms have developed. In due course, details of the design, implementation and timing of this novel study will be disclosed more fully.

The treatment of patients in the hospital setting in the SG016 study is progressing well, with more than 75 patients out of the target 100 now dosed with Synairgen's wholly-owned drug SNG001 or placebo. Results from this part of the study are still expected in June 2020.

Get out quick its dropping like a stone and never was a buy!

Tipped in the Mail on Sunday, in their Stocks to Watch column:

Https://www.thisismoney.co.uk/money/markets/article-8257007/STOCK-WATCH-Fears-grow-BPs-Alaska-sale-prove-half-baked.html

"Westminster Group

Former Tory MP Sir Tony Baldry's aptly named security company, Westminster Group, is due to reveal record first-quarter results on Thursday, but the share price has still suffered in recent weeks from the coronavirus pandemic.

That's because it provides security services to Freetown International Airport in Sierra Leone, which is shut because of the outbreak.

However, the company has seen a surge in demand for its fever screening equipment during the crisis.

I hear Westminster is poised to launch a marketing campaign that could help boost sales of its testing kit further and – investors will hope – boost its shares, too."

£3.60 ON SUCCESS

Finncap morning note from 31 MAR 20
Synairgen

First COVID-19 patient dosed

Synairgen confirmed that it has commenced dosing patients in its Phase II trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients, the first patient having been enrolled at University Hospital Southampton. A further six sites have been initiated, which are expected to start dosing in the coming days.

These sites, together with potentially three more, should enable the company to complete enrolment during April. Clearly this is a positive development and testament to the efforts of Synairgen, regulators and clinicians to help COVID-19
patients, with results expected during Q2 2020 that will determine the next action points. We reiterate our 120p target price with the prospect that this would rise by up to 240p on a positive outcome.

• First patient dosed.
The first patient has been dosed at the initial trial site at University Hospital Southampton NHS Foundation Trust. Synairgen has initiated a further 6 trial sites which are expected to start dosing in the coming days, having
previously indicated that it expects c.10 sites to participate in the trial.

• Clinical trial summary.
It is a double-blind placebo-controlled Phase II trial in hospitalised COVID-19 patients (not yet on ventilator) that will enrol 100 patients. As indicated in our report of 26 March, we think that results could be generated during Q2 2020, given an estimated two weeks to complete enrolment, two weeks to complete dosing, with a further 2-4 weeks of follow-up followed by analysis of data.

•Valuation.
We reiterate our rNPV-based target price of 120p, of which c.80p relates to the use of SNG001 in COVID-19 disease. The successful completion of the Phase II study (SG016) would imply a rNPV of as much as c.£475m or a c.360p target price – suggesting a c.£360m (240p) uplift on the current estimated NPV.

New shares-trading
Admission of the Firm Placing Shares and Total Voting Rights

Application has been made to the London Stock Exchange for the 10,943,295 Firm Placing Shares to be admitted to trading on AIM ("Firm Admission") and it is expected that Firm Admission will become effective and trading will commence in the Firm Placing Shares at 8.00 a.m. on 30 March 2020.
As you can see from RNS 26 March new shares have been on market since 30 March so whats this all about them only being available shortly ?

This looks very interesting apparently Russia Saudis and US to be in talks to lower production all round to get much higher oil price.
In fact could double the oil price if a deal can be done as they all want higher prices.
Would be geat for Hurricane.

Wouldn't be suprised to see other countries, especially the US wanting to give this a trial-bound to be more announcements soon on this front. Will then see price move a lot higher.

Just been on BBC SOUTH with photos and director talking as they start trials with 100 patients at Southampton General Hospital.

With vacines not being available for at least a year yet Synairgen could be a real winner for treating people. Possibly the only treatment available. Also with the fact its an inhaler people can use it themselves so no need for a doctor or injection.With trials now going full steam ahead results should be out in a month or two.
Price drop today lets you get in at bargain prices

EXPERTS ! all said don't panic into selling shares, so much for their advice with FTSE probably yet to drop another 30%

My figures are as follows
iNCOME is 20,000 barrels a day x 365 days a year that's 7,800,000 barrels a year.
-At $50 per barrel that's $390 ,000,000 per annum
Say the cost is $20 per barrel that's a net profit of $219,000,000 per annum
As regards cost per barrel I think original estimates of cost were based on a much lower output so as output increases the cost per barrel will decrease as a lot of the costs will be fixed cost so as production increases cost per barrel decrease.
The market value of Hurricane at today's share price is £288 Million or $370 million
If they stopped exploration and kept pumping the share price would certainly be a lot lot higher
However as it is the share price is way undervalued in my view.
I also expect that at the march capital day we will be told that the current well tests have shown that they can even pump at a higher rate.
Any comment on my figures or view anyone?

Whilst you may think this rise is just a pump the facts are that Westminster have reported 5 contracts for fever detection equipment to date THIS YEAR and some of those will quite big contracts. These are the orders received to date from around the world and you can be sure there will be more to come. Not only does this provide some great turnover for Westminster but also it brings the companies visibilty and credibility to a much higher level of awareness. This should enable them to really get a foot into the managed services and security services opportunities worldwide and should be the start of a really rapid rise in their turnover and profitability . The company at this stage is very small with a market capitilisation of only £17 million. When the TEMA contract is signed shortly and more contracts are announced todays share price will be left far behind. My target is at least 30p but could be much higher if they keep winning contracts. Don't be tempted to take short term profits, you could be very sorry

Price keeps moving up by the day-looks to me like someone is building a stake here.
I expect an announcement in a few days. Still hugely undervalued will be 50p by Xmas

Med 3000 is a drug free treatment- how often do you get an effective treatment without drugs.
This really is unique.
That's not like some of the derampers on here who seem to be on all sorts of drugs.

Have a look in the Sunday Mirror today-page 19-article art bottom of page is praising the potential of Futura Med 3000
Once the

A 10 bagger would be nice !

It is really amazing that the Dermasys gel alone has the intended effect. I wish they had discovered this earlier as it would have saved a lot of costs. However here we are with a brilliant product that is drug free and does the job. I don't think things could have turned out better and has really enlarged the available market place especially as it seems it can be used in conjuction with other products like viagra. In fact the commercial opportunity seems much larger.
If they get the regulatory approvals and the 20 year patents the share price price will certainly be higher than today .So in my view today's price maybe the last chance for you to get in cheap